An early study suggested that CD34+CD4− and CD34+CD7− cells, which make up a fraction of the leukemic cells from pediatric T-ALL patients, had leukemia-initiating properties when engrafted into NOD/SCID mice (5). This evidence concerns the gene CD34 and leukemia.